The Open COVID Journal




ISSN: 2666-9587 ― Volume 1, 2021

Note: Average publication time is 18 days between the final acceptance of revised manuscript and its publication

Editor-in-Chief:

Shunbin Ning (Biography
Shunbin Ning

Dr. Shunbin Ning is an associate professor in the Department of Internal Medicine, East Tennessee State University, USA. He is interested in the interaction between chronic viral infections and the host innate immune system, with focus on type I IFN-mediated innate immune system, DNA damage response, autophagy, and oxidative stress. The long-term goal of these studies is to identify molecular targets for immunotherapeutic and antiviral therapeutic applications.

)

Department of Internal Medicine
Quillen College of Medicine
East Tennessee State University
Johnson City, TN
USA
Email: ,



Editorial Board Members:

A. Ali
Department of Microbiology & Immunology
University of Montreal
Montreal, QC
Canada
Email:ali.ahmad@recherche-ste-justine.qc.ca

Rusliza B. Basir (Biography
Rusliza B. Basir

Dr. Rusliza Basir is currently an Associate Professor at the Faculty of Medicine & Health Sciences, Universiti Putra Malaysia. She received her Bachelor of Science (BSc. Hons) degree in Pharmacology from the University of Liverpool, UK in 1994 and Doctor of Philosophy (PhD) in Immunopharmacology from the University of Manchester, UK in 1998. Her research is focus mainly on the immunopharmacological aspects of malaria and targeting the immune system for immunotherapeutic development for the infection. She has more than 80 refereed publications in reputable journals and has presented her research works at many conferences nationally and internationally.

)

Department of Human Anatomy
Universiti Putra Malaysia
Selangor
Malaysia
Email:rusliza1909@gmail.com

Rommel Mario R. Burbano (Biography
Rommel Mario R. Burbano

Dr. Burbano holds a degree in Biomedicine from the Federal University of Pará (1989), a master's degree (1993) and a PhD in Biological Sciences (Genetics) from the Ribeirão Preto Medical School of the University of São Paulo (1998). He completed his post-doctorate in Morphology at the Discipline of Genetics at the Escola Paulista de Medicina of the Federal University of São Paulo in 2005. He is a Full Professor at the Federal University of Pará. He works in the area of Human Genetics, Cell Biology and Oncology. He is currently the Coordinator of the Molecular Biology Laboratory at Hospital Ophir Loyola, Belém, Pará.

)

Federal University of Pará
Hospital Ophir Loyola
Belém, Pará
Brazil
Email:rommel@ufpa.br

T. Craig
Department of Medicine and Pediatrics
Penn State University
Philadelphia, PA
United States
Email:tcraig@pennstatehealth.psu.edu

Shirzad Fallahi (Biography
Shirzad Fallahi

Dr. Shirzad Fallahi is Associate Professor of Medical Parasitology at Lorestan University of Medical Sciences West of Iran. He graduated from Shahid Beheshti University of Medical Sciences, Tehran, Iran in 2014 with a PhD in Medical Parasitology. He has 50 research papers on different parasitic and microbial diseases. His research interests include molecular diagnosis of infections, new molecular techniques, epidemiology of infectious and parasitic diseases, and molecular diagnosis of protozoa important in medicine. He is currently exploring new diagnostic techniques for rapid, accurate and cost- effective Coronavirus disease (COVID-19) diagnosis.

)

Department of Parasitology and Mycology
Lorestan University of Medical Sciences
Khorramabad
Iran
Email:shfupdate@gmail.com

U. Haque
Department of Biostatistics and Epidemiology
University of North Texas Health Science Center
Fort Worth, TX
USA
Email:ubydul.kth@gmail.com

Subhash C. Kothiyal (Biography
Subhash C. Kothiyal

Dr. Subhash Chandra is an Academic Researcher at the Department of Pharmaceutical Chemistry, Hemvati Nandan Bahuguna Garhwal (A Central) University Srinagar Garhwal-246174, Uttarakhand, India, since March 2010. He has 11 years experience in the fields of Teaching, Research and Industry. He had published many peer reviewed scientific articles (49), books (5) and had presented papers at many National and International conferences (42). As a seasoned researcher he had published an Indian “Patent” on Antidibetic herbal tablet from high-altitude medicinal plant of Indian Himalayan region. Moreover, as an analyst, he is keenly interested in the area of Nutraceutical, Phytochemistry, Herbal Formulation, Natural Product Research, Drug Delivery System and Analytical Methods. He has achieved Eminent, Emerging and Young Scientist award in Pharmaceutical Research-2020 and Young Scientist Award-2016 & 15 and 2012.

)

Department of Pharmaceutical Chemistry
H. N. B. (A Central University)
Uttarakhand
India
Email:subhashkothiyal@gmail.com

Shyamapada Mandal (Biography
Shyamapada Mandal

Professor (Dr.) Shyamapada Mandal, attached to the Department of Zoology, University of Gour Banga, Malda (India) since 2011. His research interest includes infectious diseases including COVID-19 and coronaviruses, molecular epidemiology of infectious diseases, drug resistances, public health, and biomedicine including probiotics. Seven national academic and research awards have been conferred to him. Published more than 100 articles/chapters/reviews. Reviewer of many scientific papers in the field of Biomedicine, and editorial board members of seven biomedical journals. Awarded PhD (Science) in 2006, from the School of Tropical Medicine (Jadavpur University), India.

)

Department of Zoology
University of Gour Banga
Malda
India
Email:samtropmed@gmail.com

G.M. Oliveira (Biography
G.M. Oliveira

Veterinarian graduated from the Fluminense Federal University, Technologist in Public Health of the Instituto Oswaldo Cruz/FIOCRUZ. Started academic career as a Scientific Initiation/CNPq student in 1997, Master and Doctor in the Cellular and Molecular Biology Program, with an emphasis on Immunology at the Instituto Oswaldo Cruz. At the Federal University of São Paulo, completed pos-doc in the Clinical Nephrology Discipline at Escola Paulista de Medicina / UNIFESP.

)

Laboratório de Biologia Celular
Instituto Oswaldo Cruz
Rio de Janeiro
Brazil
Email:gmoliveira@ioc.fiocruz.br

N. Trehanpati
Department of Molecular and Cellular Medicine
Institute of Liver and Biliary Sciences
New Delhi
India
Email:trehanpati@gmail.com

Muhammad Amin (Biography
Muhammad Amin

Dr. Muhammad Amin Ph.D., is Associate Professor of Department of Chemistry, University of Sargodha, Pakistan. His research area includes Nanochemistry, Computational Chemistry, Drug design and discovery, Biophysical chemistry. The goal is to design and discover pharmaceutical agents/Vaccines for contagious viruses by studying the theoretical aspects of virus entry to host cells and drug interaction at viral-host protein interfaces. In the context of ongoing pandemic COVID-19, I have an honor to publish my research related to drug-design, development and repurposing of FDA approved existing medicines for SARS-COV-2 related infections, the mechanisms of viral entry into host cells and genomic studies of novel corona virus.

)

Institute of Chemistry
University of Sargodha
Sargodha
Pakistan
Email:makhan1111@yahoo.com

Simone Brogi (Biography
Simone Brogi

Simone Brogi is an Assistant Professor at the Department of Pharmacy at University of Pisa (Italy). He leads the Computational Pharmacology and Toxicology Unit in the research group of Prof. Vincenzo Calderone. He graduated in 2005 in Biological Sciences from the University of Siena (Italy), where he also received his Ph.D. in Pharmaceutical Sciences in 2010. From 2011 to 2019 he directed the Molecular Modeling Unit at the Department of Biotechnology, Chemistry and Pharmacy (University of Siena) in the research group of Prof. Giuseppe Campiani. His research activity is focused on computational approaches in drug discovery.

)

Department of Pharmacy
University of Pisa
Pisa
Italy
Email:simone.brogi@unipi.it

C. Cheng (Biography
C. Cheng

Dr. Cheng Cheng is currently the group leader for HIV vaccine at Virology Lab, Vaccine Research Center, NIAID/NIH. Dr. Cheng received a PhD from Nagoya University and postdoctoral training at University of Washington. He joined the Vaccine Research Center in 2003 and has developed vaccines for HIV and Ebola. He received NIH director award for the development of cAd3-ZEBOV vaccine (2015) and NIAID merit award for fusion peptide based HIV vaccine (2019). He had worked as Lab head at Novartis Pharmaceuticals. He has 7 issued patents and published papers in Cell, Nature Medicine, Nature Communications and Immunity.

)

Virology Lab
Vaccine Research Center
Bethesda, MD
USA
Email:chcheng@mail.nih.gov

Davide Firinu (Biography
Davide Firinu

Dr. FIRINU serves in the Department of Internal medicine, Allergy and Clinical Immunology, managing the diagnostic and therapeutic processes of adults with complex diseases in inpatient and outpatient care settings. He focused his research interests on three main fields: autoimmunity/rheumatology, primary immunodeficiencies and rare diseases associated with dysregulation of immunity. Additional fields of interest are the innate and acquired responses to fungal infectious diseases and the genetic regulation of the immune system. Since 2013, he has been a representative of Biologicals Interest Group, at European Academy of Allergy and Clinical Immunology (EAACI).

)

Department of Internal medicine, Allergy and Clinical Immunology
University of Cagliari
Cagliari
Italy
Email:davide.firinu@unica.it

Eduard Karamov (Biography
Eduard Karamov

Professor Eduard Karamov is serving as the Head of Laboratory of Immunochemistry at the Gamaleya Center, Russia. Dr. Karamov graduated from the Lomonosov University of Moscow, Russia. He earned his PhD degree from the Ivanovsky Research Institute of Virology, Russia in 1974. His research is focused on HIV antivirals, microbicides, HIV vaccine, molecular epidemiology of HIV, HIV/TB coinfection, SARS-CoV-2 antivirals, virucidal agents and nanomaterials. Over the last three decades, Dr. Karamov has served as an expert of a number of international organizations.

)

Gamaleya National Research Center for Epidemiology and Microbiology
Moscow
Russian Federation
Email:karamov2004@yandex.ru

Chien-An Hu (Biography
Chien-An Hu

Professor Hu’s research interests are in molecular basis of regulated cell death, apoptosis, autophagy, necroptosis, ferroptosis, and pyroptosis, in human diseases, for example, SARS-CoV-2 infection and COVID-19. ResearchGate: https://www.researchgate.net/profile/Chien_An_Andy_Hu

)

Department of Biochemistry and Molecular Biology
University of New Mexico School of Medicine and Health Sciences Center
Albuquerque, NM
United States
Email:AHu@salud.unm.edu

D. Kouretas
Department of Biochemistry-Biotechnology
University of Thessaly
Larisa
Greece
Email:dkouret@uth.gr

N. Nakajima
Department of Medicine
Nihon University School of Medicine
Tokyo
Japan
Email:nakajima.noriko@nihon-u.ac.jp

L.K. Scott (Biography
L.K. Scott

Dr. L Keith Scott is an adult and pediatric intensivist and director of the SICU at LSU Health in Shreveport. Dr. Scott has parCcular experCse in ECMO having performed that procedure for more than 20 years. Also, he is former Chief of the CVICU at Wake Forest University. Currently he is Professor of Pediatrics, Surgery and Medicine at LSU Health. Dr. Scott also holds a master degree in Global Health and infecCous Diseases from the University of Edinburgh and is acCve in developing ICU care models in HaiC and parts of rural Africa.

)

Adult and Pediatric CF Center
Louisiana State University
Shreveport, LA
USA
Email:lscott2@lsuhsc.edu

H. Xu
School of Pharmacy
Shanghai University of Traditional Chinese Medicine
Shanghai
China
Email:xuhongxi88@gmail.com


Associate Editorial Board Members:

H. Bellali (Biography
H. Bellali

She works at the Medical Faculty of Tunis, Tunisia as associate professor in Public Health and head of the epidemiology and statistics department in A. Mami hospital from November 2016 to March 2019. She is a graduate from the France Field Epidemiology Training Programme in 2011. She has 8 years of experience in university teaching and research leading. She was the head of the international surveillance unit at the Tunisian National Observatory of New and Emerging Diseases for one year, a head of department, has conducted research at household, community, health facility, district and ecological studies and published more than 30 papers. She is a member of several technical working groups at Ministry of Health such as lymph nodes tuberculosis prevention group and “Early Warning and Response” Curriculum development pedagogy committee. She has supervised more than 20 students at Masters level and thesis.

)

Epidemiology and Statistics Department
Tunis El Manar University
Tunis
Tunisia
Email:hedia.bellali@gmail.com

P.O. Nnamani (Biography
P.O. Nnamani

Dr. Petra Obioma Nnamani is currently Humboltian at Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarland University Germany, and also Senior lecturer at the Department of Pharmaceutics, University of Nigeria, Nsukka (UNN). She obtained her B.Pharm (2001) and M.Pharm (2004) both from UNN. Petra joined the nanotechnology group at ICS-UNIDO (Trieste Italy, 2009) for Early Research Training in Nanotechnology and later obtained her PhD in Drug Delivery (2010) from UNN. She was CV Raman International Fellow at the Department of Physics, Shivaji University Kolhapur, India (2012) and TWAS-DFG Cooperation Visits Programme at HIPS (2013). Petra is a Member of NYAS, OWSD and PSN.

)

Department of Pharmaceutics
University of Nigeria
Enugu State
Nigeria
Email:petra.nnamani@unn.edu.ng

Alexsandro S. Galdino (Biography
Alexsandro S. Galdino

Dr. Alexsandro Galdino received Biological Sciences degree from Universidade Federal do Ceará (Brazil) and obtained a doctoral degree from the Universidade de Brasília (UnB) (Brazil). He has conducted post-doctoral research in UnB (2008-2010) and has been professor in Universidade Federal de São João Del-Rei (Brazil) since 2010. During his studies, Dr. Galdino dedicates efforts in the field of cloning and heterologous gene expression in microorganisms (bacteria and yeasts) to obtain innovative products for industries. Dr. Galdino produces recombinant industrial enzymes for several biotechnological applications as well as antigenic targets as input for immunological diagnosis kits.

)

Federal University of São João Del-Rei (UFSJ)
Microbial Biotechnology Laboratory
Divinopolis
Brazil
Email:asgaldino@gmail.com












Track Your Manuscript:


Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents


Webmaster Contact: info@benthamopen.net
Copyright © 2021 Bentham Open